Skip to Content

GS JT (Votrient pazopanib 200 mg)

Generic Name: pazopanib

Pill with imprint GS JT is Gray, Capsule-shape and has been identified as Votrient pazopanib 200 mg. It is supplied by GlaxoSmithKline.

Votrient is used in the treatment of soft tissue sarcoma; renal cell carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS JT

Votrient

Generic Name
pazopanib
Imprint
GS JT
Strength
pazopanib 200 mg
Color
Gray
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Vegf/vegfr inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, povidone, sodium starch glycolate type A potato, hypromelloses, ferrosoferric oxide, polyethylene glycol 400, polysorbate 80, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00173-0804 GlaxoSmithKline
00078-0670 Novartis Pharmaceuticals Corporation

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.